The Georgia Institute of Technology has been awarded up to $21.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to deliver a first-of-its-kind therapy to patients with lymphatic disease.
Georgia Tech receives major funding to develop lymphatic disease therapy
- Post author:admin
- Post published:March 4, 2026
- Post category:uncategorized